Medical Marijuana News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

14.03.17	Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release Of Study Using Its Real Scientific Hemp Oil-X™ To Treat Epileptic Children (PR Newswire)
14.03.17	Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release Of Study Using Its Real Scientific Hemp Oil-X™ To Treat Epileptic Children (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
14.03.17	Biotech Influence in Exploding Cannabis Industry Boosting Innovative Treatments and Therapies (PR Newswire)
08.03.17	Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic 'Look At America's Reverse-Cannabis Pipeline' (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech annonce que les patients inscrits entament la phase 2 de l'etude pour le traitement du syndrome du colon irritable (SCI) avec le chewing-gum CanChew... (PR Newswire)
07.03.17	Medical Marijuana, Inc.'s Investmentgesellschaft AXIM® Biotech verkündet Beginn der Phase-II-Studie mit rekrutierten Patienten zur Behandlung des Reizdarmsyndroms (RDS) mit CanChew Plus®... (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
07.03.17	Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum (PR Newswire)
06.03.17	Medical Marijuana, Inc. CEO Featured Speaker at California Cannabis Business Expo, Change.org Petition Seeks to Engage Trump Administration (PR Newswire)
01.03.17	'Greater Enforcement' of Federal Laws Would Have Mixed Impact in Cannabis Industry (PR Newswire)
28.02.17	Medical Marijuana, Inc. CEO Covered by National Mexico Media Outlets Discussing Landmark Firsts, CBD Market at A4M Mexico (PR Newswire)
28.02.17	Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses (PR Newswire)
28.02.17	Cannabis CBD Infused Products Grow in Popularity Along With Newest Medicinal Applications and Uses (PR Newswire)
23.02.17	Cannabis Products are Becoming More Acceptable (PR Newswire)
22.02.17	The Tangential Opportunities of the Cannabis Industry (PR Newswire)
21.02.17	Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™ (PR Newswire)
21.02.17	FinancialBuzz.com: Cannabis Market Brings in Significant Tax Revenues (PR Newswire)
21.02.17	Multiple Sclerosis Receives Brazilian Government Permission to be Treated with HempMeds® Brasil, Flagship Product RSHO™ (PR Newswire)
15.02.17	Medical Marijuana, Inc. Subsidiary, HempMeds Brasil Featured in 'Veja' Article Highlighting Brazilian Health Authority Approval of RSHO™ on Patients with Alzheimer's Disease (PR Newswire)
13.02.17	FinancialBuzz.com: Growing Demand for Hemp Infused Products (PR Newswire)
10.02.17	Cannabis Industry Quickly Becoming a Lucrative, Wide Open Market for Development of Innovative Products and Services (PR Newswire)
10.02.17	Cannabis Industry Quickly Becoming a Lucrative, Wide Open Market for Development of Innovative Products and Services (PR Newswire)
08.02.17	Medical Marijuana, Inc. CEO To Speak On Cannabis Industry Trends & Cannabinoid-Based Pharmaceuticals At Money Show Orlando (PR Newswire)
07.02.17	Alzheimer's Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™ (PR Newswire)
02.02.17	FinancialBuzz.com: Supply of Legal Cannabis Market Grows in North America (PR Newswire)
01.02.17	Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Begins Importation of RSHO™ Green Label Into Brazil (PR Newswire)
01.02.17	Marijuana Industry Pushing Toward Federal Acceptance, Expanded Research in 2017 (PR Newswire)
31.01.17	Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Recognizes One-Year Anniversary of First RSHO-X™ Import Permit (PR Newswire)
31.01.17	Largest U.S. Banks Host Accounts for Marijuana Businesses, Says American Banker (PR Newswire)
30.01.17	Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Launches New Website (PR Newswire)
26.01.17	Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil Highlights Vast International Media Coverage of Company Growth (PR Newswire)
25.01.17	Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of a New Product- "Kannaway® Gold Premium Hemp Oil" (PR Newswire)
25.01.17	NetworkNewsWire: Cannabis Industry Sees Cautionary Optimism amid Trump Administration Uncertainty (PR Newswire)
23.01.17	Medical Marijuana, Inc. Featured in 'International Business Times' Article Highlighting RSHO-X and the State of the Global Cannabis Industry (PR Newswire)
19.01.17	The Legal Cannabis Sector Becoming More Diversified (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
19.01.17	Medical Marijuana, Inc.'s Investmentgesellschaft AXIM® Biotech beginnt klinische RDS-Studie mit CBD-Kaugummi (PR Newswire)
19.01.17	La société d'investissement AXIM® Biotech de Medical Marijuana, Inc. entre en phase d'essai clinique pour le syndrome du côlon irritable avec un chewing-gum à base de CBD (PR Newswire)
19.01.17	Medical Marijuana, Inc. Investment AXIM® Biotech Enters IBS Clinical Trial With CBD Chewing Gum (PR Newswire)
17.01.17	Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra (PR Newswire)
13.01.17	Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia (PR Newswire)
13.01.17	Developments in the Cannabis Market (PR Newswire)
11.01.17	Phoenix TV, One of China's Largest TV Networks, Features Interviews with Medical Marijuana, Inc. CEO Stuart Titus Discussing the Economic Impact of CBD Products (PR Newswire)
11.01.17	Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Medical Marijuana Inc.

Aktien Top/Flop

Meistgelesene Nachrichten